Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

57.04

+0.49 (0.87%)

as of Jun 25, 2026, 8:00:00 pm Market Open.

1634 watching

Investor Insights

Jun 25, 2026, 12:00 am

This summary was created by AI, based on 28 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed opinions from market experts. Many analysts recognize MFC's potential, particularly highlighting its growth in Asia and successful capital generation from legacy businesses. The consensus seems to indicate a solid long-term investment due to its steady dividend yield, with several experts suggesting that patience may be required as the stock navigates short-term fluctuations. Despite some concerns about past performance and market positioning against competitors, the company's strategy and management is viewed positively. Analysts mention the current valuation as reasonable compared to peers, suggesting MFC is a better option for income rather than growth. Overall, there is a cautious optimism about MFC's capabilities and future direction.

Consensus

Hold

Valuation

Fair Value

Similar

SLF-T

PAST TOP PICK

(A Top Pick Jan 15/19, Up 30%) He is not building more on it at these levels. You have a new management team who are quietly cleaning up the problems of the previous management. They are also doing some things to push the business forward on a long term basis. It's about time people started to own it.

HOLD

Canadian insurers have been the winners this year. Volatile for a while, but the stock has rallied. Growing by mid-single digit EPS, 13-14% ROE, growing dividend, trading at 1.1x book value. Just hold it for the dividend and ride it. No more catalysts this year, but it will eventually get into the 30s. (Analysts’ price target is $29.54)

BUY

Take profits now? An income stock. Lifecos have done well this year, even though rates are low. MFC reported earnings last week and saw good growth in Asia. Their long-term growth prospects are positive. A long-term hold.

BUY

This would be the best of the life insurers. They have the cheapest valuation, the least leverage and the most opportunity for selling off legacy assets that are holding it back. It is a short term buy.

COMMENT

He used to own Manulife going into the financial crisis and have not looked at it since. It is pale in comparison to Sun Life.

HOLD

Selling insurance plus investments. Core business is doing well. Low interest rates are bad for them, but rates are not going lower. Don't rush out to sell. Good growth in core business. Good valuation. Growth in Asia.

HOLD

He almost picked MFC as a top pick, but it is moving to $25, so he chose another financial. Good earnings growth, mostly Asian. It will benefit from higher interest rates, so low rates prevent it from rising to $30. They will likely raise their dividend, so you can hold this for that dividend.

HOLD

Likes the name. Long-term, overseas operations will benefit the stock price. Insurers are doing better. Up 26% in last 12 months. Nice healthy dividend of 4.1%. (Analysts’ price target is $28.38)

BUY

MFC vs. Arc Arc is riskier while MFC is steadier. MFC is at an excellent price now, close to book value and offers a 12% ROE. Best in this sector with great Asian growth potential. They have a long way to sort out problems with long-term care in the U.S. Arc is good if you want more torque in your portfolio.

COMMENT

$35.19 is his model price, 46% upside. MFC has never gotten any respect, but he watches it. SunLife has better metrics. There's a lot of value in MFC, but financials as a whole are risky now. MFC is stuck in purgatory. Sell if it breaks below $22.60. He owns a little of this. He hasn't made up his mind about MFC.

PAST TOP PICK

(A Top Pick Oct 24/18, Up 22%) There's a lot more gas in the tank. Preferred horse in the life insurance sector. 13% ROE. Trades at 7.5x earnings. Should have a "3" handle on it. Yield is 4.2%.

BUY

Likes the chart and lifecos a lot. There's been a downtrend for 2018 and part of 2019, but we're now in an uptrend, at least rangebound. He expects yields to move higher in the future and that will lift all lifeco stocks. Meanwhile, collect the dividend.

COMMENT

They've diversified out of the interest-rate tail risk by getting more into wealth management. Good. They're growing their India and China presence. But they remain an insurance company, which means they're tied to interest rates. When rates are low, their returns are lower. You can't change a leopard's spots. However, they have raised a lot of capital.

COMMENT

He finds it is a bit of a black box. He finds it hard to understand their business because there are so many moving parts. The banks are more protected from foreign competition or ownership.

HOLD

They raised the dividend late last year and he expects another boost again. They are growing their business in Asia. Margins have been squeezed a bit with lower interest rates, but based on their recent earnings report, they are weathering it well. He thinks there is value up to $28-$30. Yield 4%

Showing 346 to 360 of 2,281 entries

Most Recent Experts

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Greg Newman

Scotia Wealth Management

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Brendan Caldwell

Caldwell Securities

Liz Young, Head of investment strategy at SoFi

SoFi

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)